A26T (p.Ala26Thr) variant of GFAP (Glial fibrillary acidic protein)

A26T (p.Ala26Thr) in GFAP (Glial fibrillary acidic protein) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely benign in the context of not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.57 / 1. The record also includes population frequency data.

A26T (p.Ala26Thr) variant details